|
End-of-day quote
Shanghai S.E.
2026-08-21
|
5-day change | 1st Jan Change | ||
| 8.170 CNY | -10.02% |
|
-8.31% | +136.81% |
| 08-04 | Harbin Pharma's Two Drugs Recommended for China's Centralized Drug Procurement Listing | MT |
| 07-30 | Harbin Pharmaceutical Gets Marketing Approval for Potassium Sulfate API | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -10.02% | -8.31% | +39.90% | +143.88% | +136.81% | +103.23% | +150.61% | +160.19% | -2.74% | 3.06B | |
| +0.88% | +6.38% | +6.81% | +20.52% | +16.82% | +76.86% | +128.23% | +363.40% | +1,487.91% | 1,119B | |
| +1.07% | +3.80% | +7.83% | +16.62% | +30.58% | +51.03% | +61.48% | +50.60% | +125.35% | 651B | |
| +1.20% | +6.21% | +3.46% | +23.52% | +15.96% | +26.47% | +76.45% | +122.99% | +294.87% | 468B | |
| +1.02% | +5.77% | +12.52% | +13.68% | +14.44% | +43.09% | +47.70% | +1.95% | +54.89% | 374B | |
| +0.85% | +4.07% | +1.50% | +6.86% | +16.26% | +23.88% | +41.58% | +49.08% | +63.46% | 302B | |
| +1.26% | +6.81% | -2.02% | -12.61% | -11.24% | +1.59% | +14.67% | +40.19% | +141.99% | 259B | |
| +1.88% | +5.81% | +19.96% | +30.20% | +34.22% | +48.54% | +68.52% | +96.54% | +153.04% | 238B | |
| +1.59% | +2.09% | -7.16% | +5.88% | -7.50% | -15.52% | -52.29% | -11.59% | +94.91% | 208B | |
| +1.87% | +5.61% | +12.16% | +11.97% | +19.05% | +25.81% | +92.42% | +101.71% | +80.40% | 181B | |
| +1.01% | +4.78% | +12.55% | +8.17% | +12.73% | +9.05% | -24.16% | -42.39% | -19.75% | 160B | |
| +1.44% | +8.36% | +13.70% | +26.41% | +20.89% | +37.89% | +56.26% | +179.83% | +459.18% | 139B | |
| +2.35% | +4.98% | +9.98% | +12.53% | +24.23% | +38.36% | +8.24% | -3.16% | +13.02% | 137B | |
| +1.48% | +4.53% | +2.85% | +1.81% | -4.57% | -9.75% | -19.98% | -12.99% | +13.24% | 110B | |
| -0.10% | +5.56% | +1.35% | +0.21% | +5.15% | +28.54% | +42.39% | +1.28% | -8.01% | 105B | |
| -1.27% | +1.13% | -5.22% | -10.53% | -14.95% | +11.29% | +65.82% | +63.66% | +544.20% | 72.56B | |
| -1.05% | +2.73% | +3.76% | +11.27% | +19.21% | +27.16% | +31.36% | +57.57% | +27.24% | 57.89B | |
| -1.17% | +0.52% | +0.88% | +23.46% | +29.80% | +70.78% | -4.17% | +1.33% | -50.14% | 55.1B | |
| -3.56% | -9.27% | -13.09% | -7.21% | -19.86% | -25.39% | +23.04% | -1.49% | +189.46% | 46.76B | |
| +0.89% | +2.11% | -1.49% | +6.08% | -3.12% | -0.74% | +12.82% | - | - | 43.6B | |
| Average | +0.08% | +2.97% | +6.01% | +16.64% | +16.75% | +28.61% | +41.05% | +64.14% | +192.76% | 236.49B | |
| Weighted average by Cap. | +1.01% | +4.81% | +6.23% | +14.32% | +15.42% | +39.67% | +61.62% | +125.26% | +457.08% |
- Stock Market
- Stocks
- 600664 Stock
- Sector Harbin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
